Literature DB >> 1354784

Filovirus clearance in non-human primates.

S P Fisher-Hoch1, G I Perez-Oronoz, E L Jackson, L M Hermann, B G Brown.   

Abstract

There has been concern in the USA and Europe about filovirus outbreaks in recently imported monkeys, and possible transmission to human beings. Healthy monkeys have been found to have low-titre immunofluorescence antibody (IFA) to Asian filoviruses (Reston and Pennsylvania viruses) as well as to the African filoviruses that caused fulminating human outbreaks in the 1970s (Ebola [Zaire] and Sudan viruses). We have assessed whether such monkeys are a risk to man. We studied 42 non-human primates; 31 were experimentally infected with African and Asian filoviruses, 6 were infected during a documented Reston filovirus outbreak, and 5 had serological evidence suggestive of recent filovirus infection. During the first 15 days after infection, virus could be routinely recovered from serum or biopsy or necropsy tissue, and Asian filovirus RNA could be detected by polymerase chain reaction. 20 to 600 days after challenge, filovirus could no longer be recovered nor viral RNA detected in 141 serum, liver, spleen, or kidney specimens. Animals surviving filovirus infection develop high-titre, cross-reacting filovirus-specific antibody 14 to 21 days after infection, and this coincides with virus clearance. Healthy monkeys with low-titre filovirus antibody may be regarded as uninfected.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354784     DOI: 10.1016/0140-6736(92)91770-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 3.  Immune barriers of Ebola virus infection.

Authors:  Anita K McElroy; Elke Mühlberger; César Muñoz-Fontela
Journal:  Curr Opin Virol       Date:  2018-02-16       Impact factor: 7.090

Review 4.  What factors might have led to the emergence of Ebola in West Africa?

Authors:  Kathleen A Alexander; Claire E Sanderson; Madav Marathe; Bryan L Lewis; Caitlin M Rivers; Jeffrey Shaman; John M Drake; Eric Lofgren; Virginia M Dato; Marisa C Eisenberg; Stephen Eubank
Journal:  PLoS Negl Trop Dis       Date:  2015-06-04

5.  Survey and Visual Detection of Zaire ebolavirus in Clinical Samples Targeting the Nucleoprotein Gene in Sierra Leone.

Authors:  Huan Li; Xuesong Wang; Wei Liu; Xiao Wei; Weishi Lin; Erna Li; Puyuan Li; Derong Dong; Lifei Cui; Xuan Hu; Boxing Li; Yanyan Ma; Xiangna Zhao; Chao Liu; Jing Yuan
Journal:  Front Microbiol       Date:  2015-12-01       Impact factor: 5.640

6.  Serological Evidence of Filovirus Infection in Nonhuman Primates in Zambia.

Authors:  Katendi Changula; Edgar Simulundu; Boniface Pongombo Lombe; Eri Nakayama; Hiroko Miyamoto; Yuji Takahashi; Hirofumi Sawa; Chuma Simukonda; Bernard M Hang'ombe; Ayato Takada
Journal:  Viruses       Date:  2021-06-30       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.